Gilead Sciences Q1 EPS Forecast Increased by Zacks Research
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research raised their Q1 2025 earnings per share estimates for shares of Gilead Sciences in a research note issued to investors on Tuesday, February 25th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will post earnings of $1.72 per share […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research raised their Q1 2025 earnings per share estimates for shares of Gilead Sciences in a research note issued to investors on Tuesday, February 25th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will post earnings of $1.72 per share […]
